General Information of Drug (ID: DMNIPCO)

Drug Name
QR-313
Indication
Disease Entry ICD 11 Status REF
Epidermolysis bullosa EC3Z Phase 1/2 [1]
Cross-matching ID
TTD ID
D0X9JR

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)